Travoprost
C26H35F3O6
500.55
[1R-[1α(Z),2β(1E,3R*),3α,5α]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl] cyclopentyl]-5-heptenoic acid, 1-methylethyl ester;
Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[(α,α,α-trifluoro-m-tolyl)oxy]-1-butenyl] cyclopentyl]-5-heptenoate [157283-68-6]
[1R-[1α(Z),2β(1E,3R*),3α,5α]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl] cyclopentyl]-5-heptenoic acid, 1-methylethyl ester;
Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[(α,α,α-trifluoro-m-tolyl)oxy]-1-butenyl] cyclopentyl]-5-heptenoate [157283-68-6]
DEFINITION
Travoprost contains NLT 96.0% and NMT 102.0% of travoprost (C26H35F3O6), calculated on the anhydrous and solvent-free basis.